Latest debt-to-equity ratio
Crinetics Pharmaceuticals Debt-to-equity ratio
Direct answer
Crinetics Pharmaceuticals's debt-to-equity ratio is 3.96%.
The verified market snapshot reports 3.96%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 22, 2026.
Get free Crinetics Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 3.96%
Explore related company data
View Crinetics Pharmaceuticals's market capitalizationView Crinetics Pharmaceuticals's price-to-book ratioView Crinetics Pharmaceuticals's return on equityView Crinetics Pharmaceuticals's 52-week price rangeView Crinetics Pharmaceuticals's revenue growthView Crinetics Pharmaceuticals's profit marginView all Crinetics Pharmaceuticals key metricsReturn to Crinetics Pharmaceuticals profile